Mie University · Clinical Research and Development Center

Research keywords臨床研究支援・腫瘍内科・医療倫理・血液内科・遺伝子変異・薬剤安全性

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Risk factors for cisplatin-induced acute kidney injury: A pilot study on the usefulness of genetic variants for predicting nephrotoxicity in clinical practice. 2020.11 Molecular and clinical oncology 13 58-2020 · 主な業績等
• DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study. 2020.06 Haematologica 105 2308-23152020 · 主な業績等
• DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 study. 2019.10 Haematologica 1052019 · 主な業績等
• Safety Evaluation of Tadalafil Treatment for Fetuses with Early-Onset Growth Restriction (TADAFER): Results from the Phase II Trial. 2019.06 Journal of clinical medicine 82019 · 主な業績等

• アルツハイマー病におけるアミロイド関連画像異常（ARIA）のリスクファクターに関する臨床研究

• Official profile